Bendamustine plus rituximab may have edge for treating indolent NHL, MCLJune 22, 2017Indolent Lymphoma
Lenalidomide-rituximab induces high CR rate in untreated follicular lymphomaJune 21, 2017Indolent Lymphoma
GALEN safe and effective in relapsed and refractory follicular lymphomaJune 20, 2017Indolent Lymphoma
Waldenström macroglobulinemia panel advises on IgM paraproteinemic neuropathiesApril 19, 2017Indolent Lymphoma
Phase III trial: VZV protects auto-HCT patientsFebruary 25, 2017Indolent LymphomaAggressive Lymphomas
Long view shows doubling of survival in non-Hodgkin lymphomaJanuary 30, 2017Aggressive LymphomasIndolent Lymphoma
Hodgkin lymphoma survival has nearly tripled since the 1950sJanuary 30, 2017Indolent LymphomaAggressive Lymphomas
Antibody face-off in follicular lymphoma gives PFS, but not OS, edge to obinutuzumabDecember 5, 2016Indolent Lymphoma
Expert panel offers treatment recommendations in Waldenström macroglobulinemiaSeptember 27, 2016Indolent Lymphoma
Triptorelin doesn’t prevent ovarian failure in young women treated for lymphomaJuly 28, 2016Indolent Lymphoma
